ArticleCancers2022

Quantitative Analysis of Plasma Cell-Free DNA and Its DNA Integrity and Hypomethylation Status as Biomarkers for Tumor Burden and Disease Progression in Patients with Metastatic Neuroendocrine Neoplasias.

Esther Mettler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.